Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma-Reference-Cited by-同舟云学术

Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma

Published:2018-12-19 Issue:1 Volume:8 Page:40-50
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Zhukova Nataliya¹^ORCID,Rajagopal Revathi²³,Lam Adrienne⁴,Coleman Lee⁴⁵⁶,Shipman Peter⁷,Walwyn Thomas²,Williams Molly¹,Sullivan Michael¹⁵⁶,Campbell Martin¹,Bhatia Kanika¹,Gottardo Nicholas G.²,Hansford Jordan R.¹⁵⁶^ORCID

Affiliation:

1. Children’s Cancer Centre; The Royal Children’s Hospital; Melbourne Victoria Australia

2. Department of Pediatric and Adolescent Clinical Hematology and Oncology; Perth Children’s Hospital; Perth West Australia Australia

3. Department of Pediatrics; University Malaya Medical Center; Kuala Lumpur Malaysia

4. Department of Radiology; The Royal Children’s Hospital; Melbourne Victoria Australia

5. Department of Pediatrics; University of Melbourne; Melbourne Victoria Australia

6. Murdoch Children’s Research Institute; Melbourne Victoria Australia

7. Department of Radiology; Perth Children’s Hospital; Perth West Australia Australia

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.1799/fullpdf

Reference50 articles.

1. Epidemiology of childhood cancer;Kaatsch;Cancer Treat Rev,2010

2. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011;Ostrom;Neuro Oncol,2014

3. Low grade gliomas in children;Chalil;J Child Neurol,2016

4. The 2016 world health organization classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol,2016

5. Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database;Qaddoumi;Cancer,2009

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies;Investigative Ophthalmology & Visual Science;2024-06-05

2. The safety and efficacy of bevacizumab in treatment of recurrent low-grade glioma: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2024-05-11

3. Visual Deficits and Diagnostic and Therapeutic Strategies for Neurofibromatosis Type 1: Bridging Science and Patient-Centered Care;Vision;2024-05-09

4. Safety of Off-Label Use of Anticancer Drugs in Oncology;Creative surgery and oncology;2024-04-18

5. Amide proton transfer weighted imaging in pediatric neuro‐oncology: initial experience;NMR in Biomedicine;2024-02-18